<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://thevitalrecord.ai/2026/06/13/roche-ventana-capivasertib-pten-approval/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-13T00:00:00.000Z</news:publication_date>
      <news:title>FDA Approves Capivasertib Plus Abiraterone for PTEN-Deficient mHSPC, Clears Roche&#39;s First IHC Companion Diagnostic for PTEN Protein Loss</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/13/salmonella-moringa-ndm1-outbreak/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-13T00:00:00.000Z</news:publication_date>
      <news:title>CDC Ties 137 Cases to Moringa Supplement Outbreaks; One Rosabella-Brand Strain Carries NDM-1 Resistance Gene</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/13/dexcom-stelo-pediatric-otc-cgm/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-13T00:00:00.000Z</news:publication_date>
      <news:title>FDA Clears Dexcom Stelo as First OTC Continuous Glucose Monitor for Children as Young as Age 2</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/13/clonal-haematopoiesis-sleep-exercise-nature/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-13T00:00:00.000Z</news:publication_date>
      <news:title>Sleep and Exercise Are Linked to Slower Clonal Blood Cell Expansion — But Only for Specific Mutations, Nature Study Finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/13/fda-nitenpyram-eua-screwworm-pets/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-13T00:00:00.000Z</news:publication_date>
      <news:title>FDA Issues First-Ever Generic Animal Drug EUA — Nitenpyram Tablets for New World Screwworm Myiasis in Dogs and Cats</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/13/d1amond-ecopipam-tourette-phase3/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-13T00:00:00.000Z</news:publication_date>
      <news:title>Ecopipam Cuts Tourette Relapse Risk by Half in Phase 3 D1AMOND Withdrawal Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/13/analysis-bundibugyo-countermeasure-gap/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-13T00:00:00.000Z</news:publication_date>
      <news:title>The Bundibugyo Lineage Is a Warning, Not Just a Diagnosis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/12/belzutifan-pembro-adjuvant-rcca-approval/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-12T00:00:00.000Z</news:publication_date>
      <news:title>FDA Approves Belzutifan Plus Pembrolizumab as First Adjuvant Combination Therapy for High-Risk Clear-Cell Renal Cell Carcinoma</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/12/lassa-fever-vaccine-phase1-lassarab/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-12T00:00:00.000Z</news:publication_date>
      <news:title>First-in-Human Lassa Fever Vaccine Reports 100% Seroconversion in Phase 1 Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/12/dmg-brain-network-survival-nature/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-12T00:00:00.000Z</news:publication_date>
      <news:title>Fatal Paediatric Brain Tumours Are Wired Into the Brain — Disrupting That Network May Extend Survival</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/12/artemisinin-resistance-zambia-southwest-africa/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-12T00:00:00.000Z</news:publication_date>
      <news:title>Preliminary Data: Artemisinin-Resistance Mutation Has Swept to 79% in Western Zambia, With Day-3 Positivity 28 Times Higher Than Eastern Zambia</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/12/integrate-iib-regonivo-gej-cancer-phase3/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-12T00:00:00.000Z</news:publication_date>
      <news:title>RegoNivo Fails to Extend Survival in Phase 3 Gastric Cancer Trial, Deflating Early-Phase Enthusiasm</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/12/us-measles-2073-cases-elimination-risk/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-12T00:00:00.000Z</news:publication_date>
      <news:title>U.S. Measles Cases Reach 2,073 Across 40 Jurisdictions — Elimination Status at Risk Before November Review</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/12/jnj-firefly-bio-kras-degrader-acquisition/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-12T00:00:00.000Z</news:publication_date>
      <news:title>J&amp;J to Acquire Firefly Bio for $1 Billion, Gaining Nobel Laureate-Backed KRAS-Targeting Degrader Antibody Conjugate Platform</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://thevitalrecord.ai/2026/06/12/cytisinicline-pdufa-june20-smoking-cessation/</loc>
    <news:news>
      <news:publication>
        <news:name>The Vital Record</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-12T00:00:00.000Z</news:publication_date>
      <news:title>FDA Decision Due June 20 on Cytisinicline — First New Smoking-Cessation Drug Since Varenicline in 2006</news:title>
    </news:news>
  </url>
</urlset>
